RxSight director granted 37,037 RSUs

Warner Robert Keith reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Warner Robert Keith reported acquisition or exercise transactions in this Form 4 filing.

RxSight, Inc. director Robert Keith Warner received an equity award of 37,037 restricted stock units (RSUs) of common stock as compensation. Each RSU represents one share of RxSight common stock, bringing his direct holdings to 78,076 shares following the grant.

The RSUs will vest in full if he continues as an Outside Director until the earlier of the one-year anniversary of the June 17, 2026 grant date or the next annual meeting of stockholders after that date. This is a non-cash award rather than an open-market share purchase.

Insider Trade Summary

Grant/Award: 37,037 shares

Grant/Award 1 txn

Insider Warner Robert Keith

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	37,037	$0.00	$0.00

Holdings After Transaction: Common Stock — 78,076 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock.
2. F2. Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026.

Key Figures

RSU grant size: 37,037 RSUs Shares after grant: 78,076 shares Grant date: June 17, 2026 +2 more

5 metrics

RSU grant size 37,037 RSUs Restricted stock unit award to Outside Director on June 17, 2026

Shares after grant 78,076 shares Director’s direct common stock holdings following the RSU award

Grant date June 17, 2026 Defined as the Date of Grant for RSU vesting conditions

Vesting schedule 100% cliff vesting Earlier of one-year after grant or next annual stockholder meeting

Award price per share $0.00 per share Non-cash grant; compensation-based acquisition of RSUs

Key Terms

restricted stock unit ("RSU"), Outside Director, 2021 Equity Incentive Plan

3 terms

restricted stock unit ("RSU") financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share"

Outside Director financial

"Subject to the Reporting Person's continuing as an Outside Director through such applicable vesting date"

2021 Equity Incentive Plan financial

"Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the RxSight (RXST) director report in this Form 4?

The filing shows director Robert Keith Warner received 37,037 restricted stock units. These RSUs are a stock-based compensation award, not an open-market purchase, and increase his direct holdings to 78,076 shares of RxSight common stock after the grant.

Is the RxSight (RXST) Form 4 transaction a stock purchase or an award?

The transaction is an award of restricted stock units, not a market purchase. Code "A" indicates a grant or other acquisition, and the price per share is listed as zero, confirming it is compensation-based rather than a cash stock buy.

How many RxSight (RXST) shares does the director hold after this RSU grant?

After receiving 37,037 restricted stock units, director Robert Keith Warner holds 78,076 shares of RxSight common stock directly. This total reflects his position following the grant, as reported in the Form 4 transaction details.

When do the granted RxSight (RXST) RSUs vest for the director?

The RSUs vest 100% on the earlier of two dates: the one-year anniversary of the June 17, 2026 grant date, or the date of the next annual meeting of stockholders, provided he continues serving as an Outside Director through the applicable vesting date.

What does each RxSight (RXST) restricted stock unit represent in this filing?

Each restricted stock unit represents a contingent right to receive one share of RxSight common stock. Once the vesting conditions are met, the RSUs convert into an equivalent number of shares delivered to the director as part of his equity compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 04:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Warner Robert Keith

(Last) (First) (Middle)

C/O RXSIGHT, INC.

100 COLUMBIA

(Street)

ALISO VIEJO CALIFORNIA 92656

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RxSight, Inc. [ RXST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	06/17/2026		A		37,037(2)	A	(1)	78,076	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock.

2. Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Jim Schindler, as Attorney-in-Fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)